Literature DB >> 26424380

Distribution of serotonin receptor 5-HT6 mRNA in rat neuronal subpopulations: A double in situ hybridization study.

L Helboe1, J Egebjerg2, I E M de Jong3.   

Abstract

The 5-HT6 receptor (5-HT6R) is almost exclusively expressed in the brain and has emerged as a promising target for cognitive disorders, including Alzheimer's disease. In the present study, we have determined the cell types on which the 5-HT6R is expressed by colocalizing 5-HT6R mRNA with that of a range of neuronal and interneuronal markers in the rat brain. Here, we show that 5-HT6R mRNA was expressed at high levels in medium spiny neurons in caudate putamen and in nucleus accumbens, as well as in the olfactory tubercle. Striatal 5-HT6R mRNA was colocalized with both dopamine D1 and D2 receptor mRNA. 5-HT6R mRNA was moderately expressed in the hippocampus and throughout cortical regions in glutamatergic neurons coexpressing vGluT1. A subset of GAD67-positive GABAergic interneurons (approximately 15%) expressed 5-HT6R mRNA in the cortex and hippocampus, the majority of which belonged to the 5-HT3a receptor (5-HT3aR)-expressing subpopulation. In contrast, 5-HT6R mRNA was only expressed to a minor extent in the parvalbumin and somatostatin subpopulations. A subset of calbindin- and calretinin-positive GABAergic interneurons expressed 5-HT6R mRNA while only a very minor fraction of VIP or NPY interneurons in forebrain structures expressed 5-HT6R mRNA. Serotonergic, dopaminergic or cholinergic neurons did not express 5-HT6R mRNA. These data indicate that the 5-HT6R is located on GABAergic and glutamatergic principal neurons, and on a subset of interneurons mainly belonging to the 5-HT3aR subgroup suggesting that the 5-HT6R is positioned to regulate the balance between excitatory and inhibitory signaling in the brain. These data provide new insights into the mechanisms of 5-HT6R signaling.
Copyright © 2015 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  5-HT(6) receptor; Alzheimer’s disease; in situ hybridization; interneuron; pyramidal cell; rat

Mesh:

Substances:

Year:  2015        PMID: 26424380     DOI: 10.1016/j.neuroscience.2015.09.064

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  17 in total

1.  5-HT6 receptor blockade regulates primary cilia morphology in striatal neurons.

Authors:  Matthew Brodsky; Adam J Lesiak; Alex Croicu; Nathalie Cohenca; Jane M Sullivan; John F Neumaier
Journal:  Brain Res       Date:  2017-01-10       Impact factor: 3.252

Review 2.  What do phasic cholinergic signals do?

Authors:  Martin Sarter; Cindy Lustig; Anne S Berry; Howard Gritton; William M Howe; Vinay Parikh
Journal:  Neurobiol Learn Mem       Date:  2016-02-18       Impact factor: 2.877

3.  Olanzapine Improved Symptoms and Olfactory Function in an Olfactory Reference Syndrome Patient.

Authors:  Alefiya Dhilla Albers; Ilaria Amato; Mark W Albers
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2017-11-14       Impact factor: 2.198

Review 4.  Hippocampal GABAergic Inhibitory Interneurons.

Authors:  Kenneth A Pelkey; Ramesh Chittajallu; Michael T Craig; Ludovic Tricoire; Jason C Wester; Chris J McBain
Journal:  Physiol Rev       Date:  2017-10-01       Impact factor: 37.312

Review 5.  Serotonin 5-HT6 Receptor Antagonists in Alzheimer's Disease: Therapeutic Rationale and Current Development Status.

Authors:  Hilda Ferrero; Maite Solas; Paul T Francis; Maria J Ramirez
Journal:  CNS Drugs       Date:  2017-01       Impact factor: 5.749

6.  Axonal CB1 Receptors Mediate Inhibitory Bouton Formation via cAMP Increase and PKA.

Authors:  Jian Liang; Dennis L H Kruijssen; Aniek C J Verschuuren; Bas J B Voesenek; Feline F W Benavides; Maria Sáez Gonzalez; Marvin Ruiter; Corette J Wierenga
Journal:  J Neurosci       Date:  2021-08-19       Impact factor: 6.167

7.  New monoamine antidepressant, hypidone hydrochloride (YL-0919), enhances the excitability of medial prefrontal cortex in mice via a neural disinhibition mechanism.

Authors:  Yong-Mei Zhang; Lu-Yu Ye; Tian-Yu Li; Fan Guo; Fei Guo; Yang Li; Yun-Feng Li
Journal:  Acta Pharmacol Sin       Date:  2021-11-22       Impact factor: 7.169

8.  Co-treatment with rivastigmine and idalopirdine reduces the propensity for falls in a rat model of falls in Parkinson's disease.

Authors:  Ajeesh Koshy Cherian; Aaron Kucinski; Ryan Wu; Inge E M de Jong; Martin Sarter
Journal:  Psychopharmacology (Berl)       Date:  2019-01-04       Impact factor: 4.530

9.  Opposing roles for serotonin in cholinergic neurons of the ventral and dorsal striatum.

Authors:  Michael S Virk; Yotam Sagi; Lucian Medrihan; Jenny Leung; Michael G Kaplitt; Paul Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-05       Impact factor: 11.205

Review 10.  Neurochemical organization of the ventral striatum's olfactory tubercle.

Authors:  Hillary L Cansler; Katherine N Wright; Lucas A Stetzik; Daniel W Wesson
Journal:  J Neurochem       Date:  2020-01-07       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.